retatrutide phase 3 triumph Achieves Up to 30.3% Average Weight Loss in TRIUMPH-1 Trial Retatrutide TRIUMPH Phase 3 Top

In that report, the incidence of pancreatic cancer was also 2.9 and 2.7 times greater with exenatide and sitagliptin, respectively, compared to other oral antidiabetic medications

Every weight loss journey is personal, and finding the right balance can be challenging

An interesting thesis

Newer does not mean cleaner

Future treatment may look like: Prescribing GLP-1s for patients with Depression and obesity Using them to manage antipsychotic-related weight gain Adding them to addiction treatment plans to reduce relapse risk What Should Patients Know

After 15 min, the mice were challenged with glucose (2.0 g/kg body weight)